Trademark Search in Canada

REATA PHARMACEUTICALS & DESIGN

View On IC.GC.CA

REGISTERED

on 18 Sept 2019

Last Applicant/ Owned by

REATA PHARMACEUTICALS INC.

2801 Gateway Drive, Suite 150Irving, TX 75063

Serial Number

1775689 filed on 5^th Apr 2016

Registration Number

TMA1055169 registered on 18^th Sept 2019

Registration expiry Date

18^th Sept 2029

Correspondent Address

NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.

1, Place Ville MarieSuite 2500, Montreal

QUEBEC

H3B1R1

REATA PHARMACEUTICALS & DESIGN

Trademark usage description

pharmaceutical preparations for the prevention and treatment of neurological disorders and degenerative nerve disorders, namely, alzheimer's disease, Read More

Vienna Information

25 . 7 . 1

Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés

25 . 7 . 6

Surfaces or backgrounds covered with circles or ellipsesSurfaces ou fonds couverts de cercles ou d'ellipses

25 . 7 . 7

Surfaces or backgrounds covered with dotsSurfaces ou fonds couverts de points

26 . 4 . 1

SquaresCarrés

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 10

Quadrilaterals containing one or more circles, ellipses or polygonsQuadrilatères contenant un ou plusieurs cercles, ellipses ou polygones

29 . 1 . 6

White, grey, silverBlanc, gris, argent

29 . 1 . 4

BlueBleu

Classification Information

Class [005]
Pharmaceutical preparations for the prevention and treatment of neurological disorders and degenerative nerve disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, demyelinating nerve disease, ALS and epilepsy; pharmaceutical preparations for the prevention and treatment of disorders of the central nervous system, namely, brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the prevention and treatment of the cardio-vascular system; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity, hypothyroidism and mitochondrial disease; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for use in oncology, ophthalmology, and the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the immune system, namely, herpes, hepatitis, HIV infections, Acquired Immune Deficiency Syndrome (AIDS), and autoimmune diseases; pharmaceutical preparations for the treatment and prevention of acute or chronic kidney disease; pharmaceutical preparations for the prevention and treatment of skin diseases and disorders, namely, fibrotic skin disease and inflammatory skin disorders.

Classification kind code

Mark Details

Serial Number

1775689

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 51 on 6^th Apr 2018	Allowance Notice Sent
Submitted for opposition 50 on 6^th Apr 2018	Allowed
Submitted for opposition 42 on 20^th Dec 2017	Advertised
Submitted for opposition 26 on 30^th Nov 2017	Approved
Submitted for opposition 27 on 10^th Oct 2017	Approval Notice Sent
Submitted for opposition 22 on 9^th Jan 2017	Search Recorded
Submitted for opposition 20 on 9^th Jan 2017	Examiner's First Report
Submitted for opposition 31 on 12^th Apr 2016	Formalized
Submitted for opposition 1 on 6^th Apr 2016	Created
Submitted for opposition 30 on 5^th Apr 2016	Filed